Company / Operating Cash Flow per Share
Immunocore Holdings plc Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.21
FY2025
5-year range
-$3.37 / $0.52
FY2021-FY2025
Trend
-140.8%
vs FY2024
Sector context
#84 of 212
Health Care
What the data says
At $-0.21, Immunocore Holdings plc's operating cash flow per share ranks #84 of 212 in the Health Care sector. Declined from $0.06 to $-0.21 over the past 2 years.
Based on SEC 10-K filings.
-0.21 in FY2025.
Declined from $0.06 to $-0.21 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 212 in Health CareTop 40% of 212This company -$0.21 Sector average -$14.72
▼
+98.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 140.8% year-over-year.
- Ranks #84 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.21 | -140.8% |
| FY2024 | $0.52 | +757.2% |
| FY2023 | $0.06 | +105.7% |
| FY2022 | -$1.08 | +68.0% |
| FY2021 | -$3.37 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026